News
-
-
REGULATED PRESS RELEASE
Déclaration hebdomadaire d'opérations effectuées du 23 au 31 décembre 2024
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from December 23 to December 31, 2024
-
PRESS RELEASE
Elmos Semiconductor SE: Supervisory Board extends appointment of successful Management Board team of CEO Dr. Arne Schneider and CSO Dr. Jan Dienstuhl
Elmos Semiconductor SE's Supervisory Board extends appointment of CEO Dr. Arne Schneider and CSO Dr. Jan Dienstuhl, ensuring continuity in leadership. Elmos focuses on automotive semiconductors -
-
-
-
PRESS RELEASE
First Phosphate clôture un placement privé sursouscrit
First Phosphate Corp. clôture un placement privé sursouscrit de 2,69 millions de dollars, émettant des actions et des unités d'actions ordinaires. Participation des initiés et attribution d'unités d'actions restreintes et actions en accord avec Première nation -
-
PRESS RELEASE
Radius Pharmaceuticals Announces Licensing Agreement with Pharmanovia to Register and Commercialize Abaloparatide in China and Select Asia Pacific Territories
Radius Pharmaceuticals grants Pharmanovia exclusive commercialization rights to abaloparatide in Asia Pacific region for osteoporosis treatment, expanding global market presence